Peter Clark

In a report published on Wednesday, Societe Generale analyst Peter Clark initiated coverage on BioAmber (NYSE: BIOA) with a Buy rating and a price target of $15.00. In the report, Societe Generale noted, "In fermenting sugar to produce the flexible C4 building block bio-succinic acid, we see...